AREV INTERNATIONAL BRANDS LTD. CORPORATE UPDATE

AREV BRANDS INTERNATIONAL LTD
PRESS RELEASE
AREV INTERNATIONAL BRANDS LTD. CORPORATE UPDATE

Vancouver, British Columbia, February 26, 2019 – AREV Brands International Ltd. (“AREV” or the “Company”) (CSE – AREV), is pleased to announce that they have closed both the property purchase to acquire real estate in Sorrento, British Columbia and the Cana Gold asset purchase, both announced in January 2019. The Company would like to give the shareholder’s an update on our progress toward our vision for the Company.

AREV is an integrated natural health and therapeutics company with a focus on manufacturing innovative products that can utilize cannabis in their formulations. Our business is not to cultivate cannabis for use in the dried flower business. It is to focus on genetics and work with LP’s who are able to contract grow our genetics for us to repurchase for extraction into ingredients that will be used in our formulations.

In Canada, under the new Cannabis act, cannabis becomes a whole new legal industry. According industry research the edibles market is expected to out pace the dried flower market in 2019. Value-add processing of unique and innovative products will be the new driver in the market. Under this model LP’s will be growers and suppliers of extracts and edibles in addition to dried flower. AREV is poised to form form partnerships with LP’s for extraction and processing.

We have engaged Spire Secure Logistics Inc. to consult on obtaining a Hemp Cultivation License on the 28 acre Sorrento BC property and have initiated the construction of a 8,500 square foot processing facility, expected to be completed in the third quarter of 2019. The company has an extraction system and a soft gel cap machine to be installed at the new facility.

AREV has 8 products registered with Health Canada which have Natural Health Product numbers and a line of award winning topical creams, sticks and oils for pain management and skin care. We also recently acquired the High Times award winning line of Cannagold Vape Pens and concentrates.

Through our ownership in BC Bud Depot and with the assistance of our newest Director Mr. Leo Ford, we are able to start a breeding business in Columbia where we will be registering our genetics. Matt Harvey, the founder of the company recently visited Columbia and will be working with Leo to launch the business in Latin America. Matt has been developing and breeding cannabis for seeds and new strains successfully for over 20 years. As a result we own an extensive line of award winning stains and genetics. BC Bud Depot has one of the largest and revered seed banks in the world containing hundreds of genetics of which over 40 have won Cannabis Cups in International competitions. Our breeders are some of the best in the world.

– We have an inventory of approximately 850,000 seeds.
– Genetics vault with over 200 varieties
– Exclusive rights to the inside covers of High Times Magazine in perpetuity and it is pre paid.
– The www.bcbuddepot.com web site has 2,000 new visits each week
– We have 50,000 names of customers in our database (15,000 in Canada)

Cannagold Concentrates
AREV recently acquired Cannagold line of Pens and Concentrates, which are well branded and ready to go in legal channels world wide.

BARE Topicals
An award winning line of topical creams, sticks and oils for pain management and skin care. People who use our most popular Heat, Recover and Magic swear by them. All natural and they work.

The Company held a meeting of the Board of Directors in Vancouver, British Columbia on February 20, 2019. The Board carefully reviewed the market, the Company’s assets and the future direction of the Company to best serve shareholders. As a result of these discussions, the Company has decided to focus their efforts on expanding the Company’s business into California and Columbia. The Company will continue to work through due diligence on JV opportunities with LP’s looking for extraction and genetics or product licensing.

In order to make room for another director in either California or Latin America and effective February 22, 2019 Stephane Maher, has resigned as a Director of the Company. The Company would like to thank Mr. Maher for all his work to date and wish you the best in all your future endeavors.

For further information, contact Mike Withrow, mike@AREVBrands.com 778-379-8551.

On behalf of the Board,

Mike Withrow
CEO & Director
About AREV Brands International Ltd.
AREV Brands International Ltd. (“AREV”) produces and delivers functional compounds and ingredients from its world-class extraction systems. AREV is revolutionizing the current delivery method of terpenes, cannabinoids and flavonoids. These premium ingredients and formulations are used in products targeted for sale in the natural health, medical, functional food, nutraceutical, sport nutrition and bioceutical markets. AREV innovates through extraction to produce extracts from specific selected plant and exude from trees that address 5 areas of health including Anxiety, Pain Management, Insomnia, Central Nervous System Disorders & Libido.

NEITHER THE CANADIAN SECURITIES EXCHANGE NOR ITS REGULATIONS SERVICES PROVIDER HAVE REVIEWED OR ACCEPT RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE.

FORWARD LOOKING INFORMATION
Neither the Canadian Securities Exchange nor its Regulation Services Provider (as that term is defined in policies of the CSE) accepts responsibility for the adequacy or accuracy of this release. This news release may include forward-looking statements that are subject to risks and uncertainties. All statements within, other than statements of historical fact, are to be considered forward looking. Although the Company believes the expectations expressed in such forward looking statements are based on reasonable assumptions, such statements are not guarantees of future performance and actual results or developments may differ materially from those in forward-looking statements. Factors that could cause actual results to differ materially from those in forward-looking statements include market prices, exploitation and exploration successes, continued availability of capital and financing, and general economic, market or business conditions. There can be no assurances that such statements will prove accurate and, therefore, readers are advised to rely on their own evaluation of such uncertainties. We do not assume any obligation to update any forward-looking statements except as required under the applicable laws. This press release contains forward-looking statements. The use of any of the words “anticipate”, “continue”, “estimate”, “expect”, “may”, “will”, “project”, “should”, “believe” and similar expressions are intended to identify forward-looking statements. Although the Company believes that the expectations and assumptions on which the forward-looking statements are based are reasonable, undue reliance should not be placed on the forward-looking statements because the Company can give no assurance that they will prove to be correct. Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. These statements speak only as of the date of this press release. Actual results could differ materially from those currently anticipated due to a number of factors and risks various risk factors discussed in the Company’s Management’s Discussion and Analysis under the Company’s profile on www.sedar.com.


Presentation Request